Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-24-008433
Filing Date
2024-11-29
Accepted
2024-11-29 06:14:07
Documents
62
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR AUGUST 2024 cnbx_i10k-83124.htm   iXBRL 10-K 862649
2 CERTIFICATION cnbx_ex3101.htm EX-31.1 11339
3 CERTIFICATION cnbx_ex3102.htm EX-31.2 11390
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 4463
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4447
6 GRAPHIC image_001.jpg GRAPHIC 13611
7 GRAPHIC image_002.jpg GRAPHIC 12960
8 GRAPHIC image_003.jpg GRAPHIC 12430
9 GRAPHIC image_004.jpg GRAPHIC 7544
10 GRAPHIC image_005.jpg GRAPHIC 29224
11 GRAPHIC image_006.jpg GRAPHIC 19346
12 GRAPHIC image_007.jpg GRAPHIC 17819
13 GRAPHIC image_008.jpg GRAPHIC 3577
14 GRAPHIC image_009.jpg GRAPHIC 23238
15 GRAPHIC image_010.jpg GRAPHIC 5482
16 GRAPHIC image_011.jpg GRAPHIC 2126
22 GRAPHIC image_012.jpg GRAPHIC 3079
  Complete submission text file 0001683168-24-008433.txt   3706450

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE cnbx-20240831.xsd EX-101.SCH 22563
18 XBRL CALCULATION FILE cnbx-20240831_cal.xml EX-101.CAL 31573
19 XBRL DEFINITION FILE cnbx-20240831_def.xml EX-101.DEF 66357
20 XBRL LABEL FILE cnbx-20240831_lab.xml EX-101.LAB 222690
21 XBRL PRESENTATION FILE cnbx-20240831_pre.xml EX-101.PRE 175093
64 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10k-83124_htm.xml XML 277284
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 241513096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)